Topic

Their treating Steady

455 applications whose title mentions it. Its share of new filings over the last two years is 45% above the four years before.

Allowance rate

69%

−6 pts vs the USPTO 375 decided

Months to first action

15.4 mo

−3.2 vs the USPTO

Applications

455.0

in the record

Allowed

259.0

116 abandoned

Filings by year

How often the topic was filed

The most recent years are still filling in.

Where it is examined

Domains and art units

CPC subclasses

A61K162 apps

C07D151 apps

C07K41 apps

C07C34 apps

A61P28 apps

C12N18 apps

Art units

162653 apps

162544 apps

OPAP33 apps

162431 apps

162830 apps

162729 apps

Examiners

Who examines it, and how it fares with each

Docket Central34 apps

n/a

Laura Lynne Stockton12 apps

83%

Golam M Shameem11 apps

90%

Bong-Sook Baek10 apps

80%

Sarah Pihonak10 apps

60%

Rebecca L Anderson8 apps

88%

John S Kenyon8 apps

50%

David K O Dell8 apps

71%

Bars show the share of decided applications that were allowed.

Unlock the examiners behind this topicIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Who files it

Companies and institutions

ASTRAZENECA AB25 apps

64%

Alkermes Pharma Ireland Limited21 apps

85%

Boehringer Ingelheim International GmbH17 apps

50%

K36 Therapeutics, Inc.13 apps

100%

CANCER RESEARCH TECHNOLOGY LIMITED12 apps

92%

Transcend Therapeutics, Inc.12 apps

100%

Bars show the share of decided applications that were allowed.

Unlock the filers behind this topicIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Who represents them

Law firms and agents

Morgan, Lewis & Bockius LLP (BO)29 apps

100%

MCCARTER & ENGLISH, LLP BOSTON24 apps

71%

ASTRAZENECA MEDIMMUNE23 apps

65%

C/O VP, IP, LEGAL18 apps

50%

Elmore Patent Law Group18 apps

82%

WILSON SONSINI GOODRICH & ROSATI13 apps

77%

Bars show the share of decided applications that were allowed.

Unlock the firms behind this topicIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Applications

Recent applications on this topic

Application	Title	Filed	Status	Rejections	RCEs	To 1st action
19599875	POTASSIUM CHANNEL ACTIVATORS AND THEIR USE IN TREATING DISORDERS INVOLVING HYPEREXC…	2026-06-22	Pending	0	0	n/a
19526131	COMPOSITIONS AND METHODS FOR FORMING AND TREATING CONDUCTIVE STRUCTURES TO IMPROVE …	2026-04-06	Pending	0	0	n/a
19522740	Heteroaryl Compounds and Their Use in Treating Medical Conditions	2026-03-25	Pending	0	0	n/a
15558177	Method and apparatus for adaptive signal processing	2012-01-10	Allowed	1	0	12.0 mo
15217670	Composition and method for controlled release	2015-02-11	Abandoned	4	1	23.0 mo
15235704	Distributed ledger transaction verification	2018-03-12	Allowed	3	0	20.0 mo
15452646	Thermal management of battery assemblies	2021-04-13	Pending	2	1	17.0 mo
15977832	Machine learning model for anomaly detection	2012-05-14	Allowed	1	0	14.0 mo
15927260	Wireless power transfer coil arrangement	2015-06-15	Abandoned	4	1	25.0 mo
15644956	Catalyst for selective hydrogenation	2018-07-16	Allowed	3	0	22.0 mo

Unlock every application on this topic, with its timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in